Dan Peer

May 18, 2023 | pubmed.ncbi.nlm.nih.gov | Dan Peer

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

May 18, 2023 | futuremedicine.com | Dan Peer

NanomedicineAhead of PrintInterviewFree AccessPublished Online:D Peer is a full professor and director of the Laboratory of Precision NanoMedicine at Tel Aviv University, where he also holds the position of vice president for research and development. He has published 160 papers so far, with over 20,000 citations and has registered many patents (135 granted and pending).

Apr 5, 2023 | science.org | Hanna Grobe |David Sprinzak |Dan Peer

AbstractThe potential of microtubule-associated protein targets for cancer therapeutics remains largely unexplored due to the lack of target-specific agents. Here, we explored the therapeutic potential of targeting cytoskeleton-associated protein 5 (CKAP5), an important microtubule-associated protein, with CKAP5-targeting siRNAs encapsulated in lipid nanoparticles (LNPs).

Mar 30, 2023 | nature.com | Dan Peer

CRISPR RNA is delivered to the mouse lung by inhalation using improved lipid nanoparticles. Many patients with inherited lung diseases lack effective treatment and could derive immense benefit from gene-editing therapies that correct the causative mutation. Direct delivery of such therapies to the lung by inhalation would be transformative, but the respiratory route of administration faces special challenges arising from physiological mechanisms that protect the lung against foreign particles.